title: Dietary carnosic acid suppresses hepatic steatosis formation via regulation of hepatic fatty acid metabolism in high-fat diet-fed mice.
abstract: In this study, we examined the hepatic anti-steatosis activity of carnosic acid (CA), a phenolic compound of rosemary (Rosmarinus officinalis) leaves, as well as its possible mechanism of action, in a high-fat diet (HFD)-fed mice model. Mice were fed a HFD, or a HFD supplemented with 0.01% (w/w) CA or 0.02% (w/w) CA, for a period of 12 weeks, after which changes in body weight, blood lipid profiles, and fatty acid mechanism markers were evaluated. The 0.02% (w/w) CA diet resulted in a marked decline in steatosis grade, as well as in homeostasis model assessment of insulin resistance (HOMA-IR) index values, intraperitoneal glucose tolerance test (IGTT) results, body weight gain, liver weight, and blood lipid levels (P < 0.05). The expression level of hepatic lipogenic genes, such as sterol regulating element binding protein-1c (SREBP-1c), liver-fatty acid binding protein (L-FABP), stearoyl-CoA desaturase 1 (SCD1), and fatty acid synthase (FAS), was significantly lower in mice fed 0.01% (w/w) CA and 0.02% (w/w) CA diets than that in the HFD group; on the other hand, the expression level of β-oxidation-related genes, such as peroxisome proliferator-activated receptor α (PPAR-α), carnitine palmitoyltransferase 1 (CPT-1), and acyl-CoA oxidase (ACO), was higher in mice fed a 0.02% (w/w) CA diet, than that in the HFD group (P < 0.05). In addition, the hepatic content of palmitic acid (C16:0), palmitoleic acid (C16:1), and oleic acid (C18:1) was significantly lower in mice fed the 0.02% (w/w) CA diet than that in the HFD group (P < 0.05). These results suggest that orally administered CA suppressed HFD-induced hepatic steatosis and fatty liver-related metabolic disorders through decrease of de novo lipogenesis and fatty acid elongation and increase of fatty acid β-oxidation in mice.
authors: Functional Food and Nutrition Division, Department of Agrofood Resources, Rural Development Administration, Suwon 441-707, Korea.
authors: Mi-Young
authors: MY
authors: Park
authors: Seong Taek
authors: ST
authors: Mun
keywords: Carnosic acid; fatty acid oxidation; hepatic steatosis; high-fat diet; lipogenesis
references: Hepatol Int. 2010 Aug 12;4(4):741-8
references: 21286345
references: Chem Pharm Bull (Tokyo). 2010 Jan;58(1):27-9
references: 20045961
references: Hepatology. 2005 Jun;41(6):1313-21
references: 15915461
references: Hepatol Res. 2011 Jan;41(1):87-92
references: 21199201
references: Endocrinology. 2013 Feb;154(2):685-97
references: 23321697
references: Fitoterapia. 2011 Apr;82(3):414-21
references: 21129455
references: Nutr Metab (Lond). 2012 Mar 30;9(1):27
references: 22458550
references: Diabetes. 2011 May;60(5):1566-76
references: 21464444
references: Chem Biol Interact. 2010 Dec 5;188(3):616-22
references: 20816777
references: Adv Nutr. 2011 Jan;2(1):15-22
references: 22211186
references: Hepatology. 2010 Feb;51(2):679-89
references: 20041406
references: Hepatology. 2003 Dec;38(6):1529-39
references: 14647064
references: Exp Ther Med. 2011 Nov;2(6):1077-1081
references: 22977624
references: Diabetologia. 2009 May;52(5):882-90
references: 19252892
references: Curr Mol Med. 2009 Apr;9(3):299-314
references: 19355912
references: J Pharm Biomed Anal. 2013 Apr 15;77:21-8
references: 23384548
references: Biochim Biophys Acta. 2009 Nov;1792(11):1080-6
references: 19733654
references: Eur J Pharmacol. 2006 Apr 24;536(1-2):182-91
references: 16574099
references: Rev Med Chir Soc Med Nat Iasi. 2012 Apr-Jun;116(2):425-31
references: 23077931
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: Nutr Metab (Lond). 2013 Feb 02;10(1):19
references: 23374457
references: Diabetologia. 2006 Apr;49(4):755-65
references: 16463046
references: Proc Natl Acad Sci U S A. 2009 Sep 8;106(36):15430-5
references: 19706383
references: Curr Opin Lipidol. 2008 Jun;19(3):248-56
references: 18460915